DBS analyst Dale Lai maintained a Buy rating on ESR-REIT (CGIUF – Research Report) today and set a price target of S$0.31. The company’s shares ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

In a report released today, Dale Lai from DBS maintained a Buy rating on Digital Core REIT (DCRU – Research Report), with a price target of ...

The organization is pushing forward with implementation of an ambitious community development agenda, with the help of community partners.

Founded in 2010 and administered by a six-strong Board of Trustees, the Meningitis Foundation Aotearoa New Zealand strives to ...

Expansile lesions in the hand mostly involve phalanges and metacarpals. Among them, majority comprising enchondroma and less ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs. placebo; Achieved statistical significance ...

As the U.S. Army continues its transition back to large-scale combat operations, it must also place emphasis on reserve ...

The policy aims to position Karnataka as a leader in sustainable industrial practices through incentives for green ...

Cuscaden Peak expects to spend between $300 million and $600 million to refurbish the Paragon mall, taking between three and ...